Health group Ascendis, which has been battling with a hefty debt pile and the threat of being forced to sell its most profitable assets, has reported that interim operating profits were up more than a third amid robust demand for vitamins and supplements during the Covid-19 pandemic.

A move to recapitalise the group is also looking more likely, with Ascendis saying two of its lenders, who want a halt to asset disposals, have now increased their share of the group’s debt vehicle to three-quarters...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now